Drawing for PIPETTE AND FORGET

USPTO serial 79375985

PIPETTE AND FORGET

Reviewed by CopyMark Law Group

Reg. 7561499Status 700Registered
Filing date
Status date
Registration date
Nov 12, 2024
Examiner
DAVIS, ALEXIS A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PIPETTE AND FORGET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca Liebowitz

Rebecca Liebowitz Venable LLPP.O. Box 34385Comberton Road, ToftWashington, DC 20043-9998

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for scientific purposes; chemical preparations, enzymes, gene editing enzymes, oligonucleotides, and proteins for scientific and industrial purposes; genes, DNA and RNA being nucleic acid sequences for scientific and industrial purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA and synthetic genes being nucleic acid sequences for scientific and industrial purposes; synthetic oligonucleotides and synthetic proteins for scientific and industrial use; chemicals, reagents and enzymes for use in the preparation and creation of synthetic DNA, synthetic RNA, synthetic genes being nucleic acid sequences for scientific and industrial purposes; molecular biology research tools in the nature of biological and biochemical reagents; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, oligonucleotides, genes and proteins for scientific and industrial purposesACTIVE—
005Biological, chemical and biochemical reagents, namely, proteins, and gene editing enzymes, all for medical diagnostic use; synthetic proteins for medical diagnostic use; vaccinesACTIVE—
009Scientific laboratory apparatus and instruments, namely, scientific desktop instruments for DNA, RNA, gene and protein synthesis for scientific use; scientific desktop instruments for DNA, RNA, gene and protein synthesis, namely, microfluidic devices; cartridges containing biological samples for use in scientific apparatus in connection with DNA, RNA, gene, cell and protein synthesis and characterisation instruments, namely, microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors in the nature of sensor chips for scientific, research or industrial purposes in DNA, RNA, gene and protein synthesis; biochips in the nature of microchips; scientific research and laboratory apparatus, namely, apparatus and instruments for amplifying DNA and RNA, namely, reactors, bioreactors, and laboratory apparatus and instruments for amplifying DNA and RNA using thermocyclers, not for medical purposes; apparatus and instruments for synthesising DNA and RNA, namely, microarrays, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips, not for medical purposes; scientific research and laboratory apparatus, namely, apparatus and instruments for processing DNA and RNA, namely scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, biosensors, and biochips; computer hardware; recorded computer software, downloadable computer software and downloadable bioinformatics software for use in DNA, RNA, gene and protein synthesis in the fields of biotechnology, drug discovery and medical scienceACTIVE—
010Medical apparatus and instruments used for DNA and RNA testing and analysis and genetic testing, all for medical purposes; apparatus and instruments for DNA and RNA analysis, DNA and RNA sequencing and protein synthesis in the nature of microfluidic chips, microfluidic cartridges, micro-electromechanical chips, bio sensors, and bio-chips for medical and veterinary purposes; apparatus for DNA, RNA, gene and protein synthesis in the nature of microfluidic chips, microfluidic cartridges, micro-electromechanical chips, bio sensors, and bio-chips for medical and veterinary purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 3, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 12, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 12, 2025FIMPFINAL DISPOSITION PROCESSED—
Mar 1, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 1, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 1, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 12, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 24, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 8, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 8, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 12, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 12, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 27, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 22, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 11, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jul 11, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 11, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 11, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 13, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 13, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 13, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2024RFNTREFUSAL PROCESSED BY IB—
Mar 6, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 5, 2024RFRRREFUSAL PROCESSED BY MPU—
Feb 10, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 10, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2024DOCKASSIGNED TO EXAMINER—
Aug 15, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 11, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 10, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance